25 LLC’s Boston Scientific BSX Stock Holding History

25 LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$1.06K	–	114
2023 Q2	$1.06K	Buy	20 +10	+100%	+$522	﹤0.01%	274
2023 Q1	$532	Buy	+10	New	+$471	﹤0.01%	317

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

25 LLC's BSX Position: Q3 2023 in Review

25 LLC sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 20 shares — an estimated $1.06K sold.

25 LLC first reported a position in BSX in Q1 2023 and held it in 2 quarters. The position peaked at $1.06K in Q2 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

25 LLC reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
25 LLC sold 20 Boston Scientific shares in Q3 2023, an estimated $1.06K.
25 LLC first reported a position in Boston Scientific in Q1 2023 and held it in 2 quarters.
25 LLC's Boston Scientific position peaked at $1.06K in Q2 2023.
1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.